Publications

View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.

August 2024

Effects of mirikizumab on histologic resolution of Crohn's sisease in a randomised controlled Phase 2 trial

Clin Gastroenterol Hepatol 2024;22:1878–88. DOI 10.1002/cgh.20059

Magro F,

Chan LS,

Hon E,

Pai R,

Magro et al. evaluated histologic outcomes for mirikizumab in Crohn's disease and found that early combined histologic-endoscopic response was associated with endoscopic remission after 1 year of treatment.

Keywords:

Efficacy,
Interleukin-23,
Remission